FDA approves Eli Lilly’s GLP-1 pill

FDA approves Eli Lilly's GLP-1 pill

Food of the United States And the FDA on Wednesday approved a new obesity pill called Foundive. Taken once a day, the pill is made by the pharmaceutical company Eli Lilly, which also produces the popular weight loss injection Zepbound. Foundayo is a type of drug known as GLP-1, a category that includes competitors Ozympic … Read more

A major review of GLP-1 drugs takes a closer look at the risks and rewards

An x-ray image of an ulnar fracture.

Moderate-to-high-quality evidence from umbrella reviews on non-cardiometabolic outcomes supported associations between GLP-1 therapy and risks of nausea, vomiting, and diarrhea. High-quality evidence indicates a possible protective association between GLP-1 medication and infection-related outcomes, particularly serious infections. Exploratory indications also suggest a possible reduction in the risk of falls, respiratory disease events, and all-cause dementia. A … Read more

Creatine brand health startup raises $20 million in fresh funding

Creatine + Electrolyte Mix bag on the countertop

Create Wellness on Monday launched Creatine + Electrolyte Mix, available on Create’s website, Amazon, and in-store exclusively at Target. Create prosperity Create Wellness, the creatine gummy supplement brand, has raised $20 million in new funding amid a long-term rise in the American fitness and muscle building supplement market. The round was led by Allied Consumer … Read more

The new FDA-approved ‘Wegovy HD’ offers three times the dose of semaglutide

Wegovy FlexTouch 2.4 mg weight loss injectable medicine box and pen.

The U.S. Food and Drug Administration announced Thursday that it is approving a new, high-dose Vigovi (semglutide) injection. The 7.2 mg dose, called Vigovi HD, is intended for weight loss and long-term weight loss maintenance in adult patients. This is three times the previous maximum dose of 2.4 mg. This marks the fourth approval in … Read more